COMP <GO>
OFIX vs JNJ // 10Y YIELD & FRED MACRO BETA
Orthofix Medical Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: OFIX 2
— JNJ 8
■ METRIC PARITY
LAST: $10.24 (+1.99%) • MKT CAP: $417.1M
macro-sensitivity
—
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFIX VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OFIX | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.80% | 67.90% | +0.90 | OFIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.20% | 25.50% | -37.70 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.99% | 2.97% | +5.02 | OFIX | /fcf-yield <GO> |
| Operating Margin | -9.90% | 34.70% | -44.60 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -11.20% | 28.50% | -39.70 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 2.90% | 6.00% | -3.10 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.02 | 5.59 | -4.57 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.3 | 62.1 | -19.80 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $417.1M | $662.49B | -$662.07B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OFIX REV | JNJ REV | OFIX GROSS % | JNJ GROSS % | OFIX FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $822.3M | $94.19B | 68.8% | 67.9% | $33.3M | $19.70B |
| FY 2024 | $799.5M | $88.82B | 68.3% | 69.1% | $25.8M | $19.84B |
| FY 2023 | $746.6M | $85.16B | — | — | -$45.8M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFIX // BETA —
JNJ // BETA 1.08